Clinical Updates & Insights

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

Stay Informed
Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes.
Newsletter Sign Up
229 Clinical Updates found
Medical oncologist Alexander Drilon is Chief of MSK’s Early Drug Development Service. He specializes in lung cancer and early-phase clinical trials
Including AYA Patients in Cancer Clinical Trials

MSK physicians and researchers design and conduct clinical trials that include adolescent and young adult (AYA) cancer patients, ensuring they are not lost between the typical siloes of adult and pediatric cancer trials.
Lead study author Andrea Cercek, MD, is Section Head, Colorectal Cancer and Co-Director of the Center for Young Onset Colorectal and Gastrointestinal at MSK
When Tailoring Cancer Treatment, Biology Matters More than Age

Early-onset colorectal cancer (CRC) is likely clinically and genomically indistinguishable from average-onset cancer, according to a recent study published in the Journal of the National Cancer Institute by MSK investigators.
Neurologist Dr. Adrienne Boire in her lab
Altered Mental Status in Cancer Patients after COVID-19 Driven by “Cytokine Storm” in CSF

MSK research team identifies unique markers of inflammation and neurodegeneration found in cerebrospinal fluid of cancer patients with altered mental status after initial SARS-CoV-2 infection, as likely cause of neurologic dysfunction.
MSK HPB surgeons
Minimally Invasive Surgery of Right Superior Liver Segments Safe and Effective

Minimally invasive surgery (MIS) to resect liver segments 7 and 8 is safe for select patients treated by experienced MIS hepatopancreatobiliary surgeons.
Dr. Mark Bilsky with a patient
Surgical Resection of Benign Spine Tumors Rapidly Improves Patients’ Quality of Life

Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes.
David Solit, MD
Clinical Update
Next-generation sequencing "not overhyped": MSK-IMPACT hits 65,000 samples and counting

At Memorial Sloan Kettering Cancer Center, we have now analyzed more than 50,000 samples in our prospective cohort with MSK-IMPACT™.
Audree B. Tadros
Breast Conservation Therapy Doesn't Compromise Outcomes in Younger Breast Cancer Patients

Breast conservation therapy as an initial treatment did not compromise survival outcomes compared to mastectomy in breast cancer patients under the age of 35.
CD4+ T cell
MSK Kids: Early Immune Cell Reconstitution Predicted Improved Survival Outcomes in Patients with Graft-versus-Host Disease

Early CD4+ T cell reconstitution predicted non-relapsing mortality and overall survival in pediatric patients who received an allogeneic hematopoietic stem cell transplant (HCT) and developed acute graft-versus-host disease.
Patient is examined at MSK Kids
MSK Kids: Retinoblastoma with Choroidal Invasion Successfully Managed with Ophthalmic Artery Chemosurgery, Avoiding Enucleation

Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation.
Ilya Laufer
Overall Survival After Surgery for Spinal Metastases Has Improved Over the Last Two Decades

Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine.